Angiogenesis of renal cell carcinoma: perfusion CT findings

被引:66
作者
Chen, Yan [1 ,2 ]
Zhang, Jin [1 ,2 ]
Dai, Jingrui [1 ,2 ]
Feng, Xiaoli [2 ,3 ]
Lu, Haizhen [2 ,3 ]
Zhou, Chunwu [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Canc Hosp & Inst, Dept Diagnost Radiol, Beijing 100037, Peoples R China
[2] Peking Union Med Coll, Beijing 100021, Peoples R China
[3] Chinese Acad Med Sci, Canc Hosp & Inst, Dept Pathol, Beijing 100037, Peoples R China
来源
ABDOMINAL IMAGING | 2010年 / 35卷 / 05期
关键词
Renal cell carcinoma; Tomography; X-ray computed; Perfusion imaging; Tumor angiogenesis; Microvascular density; Vascular endothelial growth factor; TUMOR ANGIOGENESIS; MICROVESSEL DENSITY; ANTIANGIOGENIC THERAPY; PULMONARY NODULES; FUNCTIONAL-CT; ROW CT; EXPRESSION; TNP-470; GROWTH; CANCER;
D O I
10.1007/s00261-009-9565-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
To observe the perfusion CT findings of renal cell carcinoma (RCC) and prospectively correlate perfusion CT parameters with tumor MVD and VEGF expression. Dynamic contrast-enhanced multislice spiral CT was performed prospectively in 73 cases with histologically proven RCC (65 clear cell, 3 papillary, and 5 chromophobe). Blood flow (BF), blood volume (BV), mean transit time (MTT), and permeability surface-area product (PS) of RCC and normal renal cortex were measured, respectively. The tumor MVD count and VEGF expression level were determined by immunohistochemistry with specific monoclonal antibodies. There was significant difference between BF, BV, MTT, and PS of normal renal cortex (454.32 +/- A 110.90 mL/min/100 g, 23.53 +/- A 5.71 mL/100 g, 3.62 +/- A 1.38 s, 63.95 +/- A 18.85 mL/min/100 g) and RCC (261.96 +/- A 175.86 mL/min/100 g, 17.17 +/- A 8.34 mL/100 g, 7.08 +/- A 3.42 s, 25.07 +/- A 13.20 mL/min/100 g) (P < 0.01). BF and BV among RCC histologic subtypes were significantly different (P < 0.05), MTT and PS were not (P > 0.05). MVD (42.29 +/- A 21.00) of RCC is positively correlated with BF, BV, and PS (P < 0.01), not with MTT (P > 0.05). No relationship was found between the expression levels of VEGF and any perfusion CT parameter. Perfusion CT is a feasible technique to assess tissue perfusion in patients with RCC. BV, BF, and PS correlate positively with MVD and may reflect angiogenesis of RCC.
引用
收藏
页码:622 / 628
页数:7
相关论文
共 30 条
  • [1] TUMOR VASCULAR-PERMEABILITY FACTOR STIMULATES ENDOTHELIAL-CELL GROWTH AND ANGIOGENESIS
    CONNOLLY, DT
    HEUVELMAN, DM
    NELSON, R
    OLANDER, JV
    EPPLEY, BL
    DELFINO, JJ
    SIEGEL, NR
    LEIMGRUBER, RM
    FEDER, J
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (05) : 1470 - 1478
  • [2] Tumor angiogenesis:: pathophysiology and implications for contrast-enhanced MRI and CT assessment
    Cuenod, CA
    Fournier, L
    Balvay, D
    Guinebretière, JM
    [J]. ABDOMINAL IMAGING, 2006, 31 (02): : 188 - 193
  • [3] Pancreatic Endocrine Tumors: Tumor Blood Flow Assessed with Perfusion CT Reflects Angiogenesis and Correlates with Prognostic Factors
    d'Assignies, Gaspard
    Couvelard, Anne
    Bahrami, Stephane
    Vullierme, Marie-Pierre
    Hammel, Pascal
    Hentic, Olivia
    Sauvanet, Alain
    Bedossa, Pierre
    Ruszniewski, Philippe
    Vilgrain, Valerie
    [J]. RADIOLOGY, 2009, 250 (02) : 407 - 416
  • [4] Magnetic resonance imaging - Measured blood flow change after antiangiogenic therapy with PTK787/ZK 222584 correlates with clinical outcome in metastatic renal cell carcinoma
    de Bazelaire, Cedric
    Alsop, David C.
    George, Daniel
    Pedrosa, Ivan
    Wang, Yongyu
    Michaelson, M. Dror
    Rofsky, Neil M.
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (17) : 5548 - 5554
  • [5] Dhanabal M, 1999, CANCER RES, V59, P189
  • [6] Pilot study of DCE-MRI to predict progression-free survival with sorafenib therapy in renal cell carcinoma
    Flaherty, Keith T.
    Rosen, Mark A.
    Heitjan, Daniel F.
    Gallagher, Maryann L.
    Schwartz, Brian
    Schnall, Mitchell D.
    O'Dwyer, Peter J.
    [J]. CANCER BIOLOGY & THERAPY, 2008, 7 (04) : 496 - 501
  • [7] FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
  • [8] Antitumor effects of angiogenesis inhibitor 0-(chloroacetyl-carbamoyl) fumagillol (TNP-470) against murine renal cell carcinoma
    Fujioka, T
    Hasegawa, M
    Ogiu, K
    Matsushita, Y
    Sato, M
    Kubo, T
    [J]. JOURNAL OF UROLOGY, 1996, 155 (05) : 1775 - 1778
  • [9] Galvez M, 2004, AM J NEURORADIOL, V25, P1205
  • [10] Colorectal Tumor Vascularity: Quantitative Assessment with Multidetector CT-Do Tumor Perfusion Measurements Reflect Angiogenesis?
    Goh, Vicky
    Halligan, Steve
    Daley, Frances
    Wellsted, David M.
    Guenther, Thomas
    Bartram, Clive I.
    [J]. RADIOLOGY, 2008, 249 (02) : 510 - 517